430 related articles for article (PubMed ID: 29884931)
1. Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension.
Vallée A; Lévy BL; Blacher J
Curr Hypertens Rep; 2018 Jun; 20(7):62. PubMed ID: 29884931
[TBL] [Abstract][Full Text] [Related]
2. PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.
Vallée A; Vallée JN; Lecarpentier Y
Mol Psychiatry; 2019 May; 24(5):643-652. PubMed ID: 30104725
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
4. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment.
Vallée A; Lecarpentier Y; Vallée JN
Front Immunol; 2021; 12():666693. PubMed ID: 33927728
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin regulates blood pressure and kidney injury in rats.
Xiao L; Xu B; Zhou L; Tan RJ; Zhou D; Fu H; Li A; Hou FF; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1313-1322. PubMed ID: 30710617
[TBL] [Abstract][Full Text] [Related]
6. Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Cell Mol Neurobiol; 2018 May; 38(4):783-795. PubMed ID: 28905149
[TBL] [Abstract][Full Text] [Related]
7. PPARγ agonists: Potential treatments for exudative age-related macular degeneration.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Life Sci; 2017 Nov; 188():123-130. PubMed ID: 28887057
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.
Sabatino L; Pancione M; Votino C; Colangelo T; Lupo A; Novellino E; Lavecchia A; Colantuoni V
World J Gastroenterol; 2014 Jun; 20(23):7137-51. PubMed ID: 24966585
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.
Vallée A; Lecarpentier Y; Vallée JN
Cells; 2019 Jul; 8(7):. PubMed ID: 31311204
[TBL] [Abstract][Full Text] [Related]
12. Hypothesis of Opposite Interplay Between the Canonical WNT/beta-catenin Pathway and PPAR Gamma in Primary Central Nervous System Lymphomas.
Vallée A; Lecarpentier Y; Vallée JN
Curr Issues Mol Biol; 2019; 31():1-20. PubMed ID: 30647194
[TBL] [Abstract][Full Text] [Related]
13. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659554
[TBL] [Abstract][Full Text] [Related]
14. Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Neurosci Bull; 2018 Jun; 34(3):573-588. PubMed ID: 29582250
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming energetic metabolism in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
[TBL] [Abstract][Full Text] [Related]
16. The regulation effect of WNT-RAS signaling in hypothalamic paraventricular nucleus on renal fibrosis.
Zhou G; Li J; Zeng T; Yang P; Li A
J Nephrol; 2020 Apr; 33(2):289-297. PubMed ID: 31392659
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling and renin-angiotensin system in chronic kidney disease.
Zhou L; Liu Y
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):100-6. PubMed ID: 26808707
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.
Wang Z; Yang S; Li Y; Zhou Y; Liu D; Liu J; DiSanto ME; Zhang X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902342
[TBL] [Abstract][Full Text] [Related]
19. Multiple genes of the renin-angiotensin system are novel targets of Wnt/β-catenin signaling.
Zhou L; Li Y; Hao S; Zhou D; Tan RJ; Nie J; Hou FF; Kahn M; Liu Y
J Am Soc Nephrol; 2015 Jan; 26(1):107-20. PubMed ID: 25012166
[TBL] [Abstract][Full Text] [Related]
20. Geraniol protects against cyclosporine A-induced renal injury in rats: Role of Wnt/β-catenin and PPARγ signaling pathways.
Mahmoud NM; Elshazly SM; Rezq S
Life Sci; 2022 Feb; 291():120259. PubMed ID: 34968469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
